Know Your Breast Cancer 2017-06-15T17:12:39+00:00
Agendia Building

What is Genomic Testing?

Genomic tests are not the same as genetic tests. Genomic tests look at the specific genes in a tumor to find out what is driving its growth. Genetic tests determine your inherited risk or hereditary predisposition for cancer. Early-stage breast cancer patients benefit from MammaPrint genomic testing to learn about risk of recurrence and personalized treatment options.

GENOMIC VS GENETIC >>
MAMMAPRINT GENOMIC TESTING >>

 

MammaPrint®

The majority of women with early-stage breast cancer have a Low Risk of cancer relapse based on genomic testing and may safely avoid chemotherapy.1  So how do you know if chemotherapy will benefit you? The MammaPrint 70-Gene Test is currently the only FDA-cleared test for risk of disease recurrence within five years for women of all ages. The test provides a personalized, binary result so you can know if you are Low Risk for cancer relapse – and not likely to show a significant benefit from chemotherapy.

1. Cardoso F, van’t Veer LJ, Bogaerts J et al. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. N Engl J Med. 2016; 375:717-29.

LOCATE A PHYSICIAN >>

 

MammaPrint: The clarity you need when it matters most.

You have just been diagnosed with cancer and it is a difficult time for you and your loved ones. You want control of the situation, clarity in your options and confidence in the treatment decision you make.
This video describes the path of three patients after their diagnosis and how MammaPrint test results helped inform them and their physician with their treatment management plans.

LEARN MORE ABOUT MAMMAPRINT >>

Join the Symphony Sisterhood.

Tens of thousands of breast cancer
patients are part of our community.

Visit our Facebook page today.

sisterhood